hydralazine has been researched along with Cardiovascular Pregnancy Complications in 101 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated 16 pregnant women with gestational age between 20 and 32 weeks in acute severe hypertension which were randomly allocated to receive either hydralazine or labetalol." | 9.15 | Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. ( Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP, 2011) |
| "The purposes of this study were to compare the efficacy of sublingual nifedipine with intravenous hydrallazine in the control of acute hypertension of pregnancy and to make a preliminary assessment whether sublingual nifedipine could be recommended for use by midwives faced with severe hypertension in pregnancy in a rural setting." | 9.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "To evaluate the effect of hydralazine on placental circulation in cases of pre-eclampsia, Doppler ultrasonography was used to record blood velocity in the arcuate and umbilical arteries in 12 pregnancies complicated by pre-eclampsia, blood velocity in the maternal renal artery also being examined." | 9.08 | Effects of hydralazine on placental and renal circulation in pre-eclampsia. ( Gennser, G; Gudmundsson, S; Marsal, K, 1995) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 9.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "Labetalol (Trandate; Allen & Hanburys), a combined alpha- and beta-adrenergic blocking agent, was compared with the more commonly used peripheral vasodilator, dihydrallazine (Nepresol; Ciba), each administered as an infusion, in the treatment of severe hypertension in 20 primigravidas at greater than or equal to 32 weeks' gestation." | 9.06 | Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. ( Ashe, RG; Moodley, J; Philpott, RH; Richards, AM, 1987) |
| "Patients with acute pregnancy-related hypertension were randomized to treatment with 200 mg oral labetalol or 10 mg intramuscular hydralazine." | 9.05 | Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. ( Calder, AA; Greer, I; Walker, JJ, 1983) |
| "In an open, controlled trial, treatment with a combination of metoprolol and hydralazine was compared with non-pharmacological management of mild and moderate hypertension in pregnancy." | 9.05 | A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. ( Axelsson, O; Högstedt, S; Lindberg, BS; Lindeberg, S; Lindmark, G; Rane, A; Sandström, B, 1985) |
| "Twentysix women with pregnancy-induced hypertension have been randomly treated with either labetalol or Aldomet." | 9.05 | Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. ( Broughton Pipkin, F; Lamming, GD; Symonds, EM, 1980) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 9.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| " Plasma renin activity (PRA), the daily urinary excretion of aldosterone (dU-Aldo) and electrolytes were studied before and during dihydralazine therapy (25 mg 3 times daily)." | 9.04 | The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy. ( Lammintausta, R, 1978) |
| "To review outcomes in randomised controlled trials comparing hydralazine against other antihypertensives for severe hypertension in pregnancy." | 8.82 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. ( Cham, C; Magee, LA; Ohlsson, A; von Dadelszen, P; Waterman, EJ, 2003) |
| "Tradiational drug therapy choices for hypertension in pregnancy continue to be hydralazine for acute reduction of blood pressure and methyldopa for the management of chronic hypertension." | 8.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| "Acute cocaine intoxication has been associated with elevated blood pressure and placental abruption." | 7.68 | Cocaine intoxication associated with abruptio placentae. ( Clark, JF; Flowers, D; Westney, LS, 1991) |
| "The hemodynamic changes after intravenous administration of hydralazine were assessed using M-mode echocardiography in 13 pregnant patients with severe hypertension." | 7.67 | Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. ( Kuzniar, J; Piela, A; Skret, A; Szmigiel, Z; Zaczek, T, 1985) |
| " The mother suffered from lupus-like syndrome consequent to hydralazine treatment for pregnancy-induced hypertension." | 7.67 | Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report. ( Bar-Khayim, Y; Dgani, R; Lancet, M; Mogilner, BM; Nissim, F; Shoham, Z; Yemini, M, 1989) |
| "The uteroplacental blood flow was measured in 12 women with hypertension during pregnancy before and after intravenous injection of dihydralazine." | 7.66 | Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Thornström, S, 1983) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 7.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "Hydralazine was found to be superior in its ability to effect more rapidly a lower mean arterial blood pressure." | 6.66 | Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. ( Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM, 1989) |
| " The duration of action also varied in the labetalol group, with the shortest duration occurring in those patients who required the highest dosage for BP control." | 6.66 | A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. ( Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM, 1987) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 5.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| "We evaluated 16 pregnant women with gestational age between 20 and 32 weeks in acute severe hypertension which were randomly allocated to receive either hydralazine or labetalol." | 5.15 | Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. ( Baggio, MR; Berezowski, AT; Calderon, AC; Cavalli, RC; Duarte, G; Marcolin, AC; Martins, WP, 2011) |
| "The purposes of this study were to compare the efficacy of sublingual nifedipine with intravenous hydrallazine in the control of acute hypertension of pregnancy and to make a preliminary assessment whether sublingual nifedipine could be recommended for use by midwives faced with severe hypertension in pregnancy in a rural setting." | 5.08 | Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice. ( Jegasothy, R; Paranthaman, S, 1996) |
| "To evaluate the effect of hydralazine on placental circulation in cases of pre-eclampsia, Doppler ultrasonography was used to record blood velocity in the arcuate and umbilical arteries in 12 pregnancies complicated by pre-eclampsia, blood velocity in the maternal renal artery also being examined." | 5.08 | Effects of hydralazine on placental and renal circulation in pre-eclampsia. ( Gennser, G; Gudmundsson, S; Marsal, K, 1995) |
| "Fifty-one women with pregnancy-induced hypertension (PIH) were randomly allocated to one of three treatment groups: A: hydralazine (13); B: hydralazine and propranolol (17); and C: hydralazine and pindolol (19)." | 5.08 | Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. ( Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E, 1995) |
| "Forty-four consecutive patients referred for treatment because of hypertension (greater than 150/90 mmHg) occurring during pregnancy were randomly allocated to one of two treatment groups, hydralazine alone (n = 21) or hydralazine combined with pindolol (n = 23)." | 5.06 | Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. ( Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E, 1986) |
| "Labetalol (Trandate; Allen & Hanburys), a combined alpha- and beta-adrenergic blocking agent, was compared with the more commonly used peripheral vasodilator, dihydrallazine (Nepresol; Ciba), each administered as an infusion, in the treatment of severe hypertension in 20 primigravidas at greater than or equal to 32 weeks' gestation." | 5.06 | Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy. ( Ashe, RG; Moodley, J; Philpott, RH; Richards, AM, 1987) |
| "Patients with acute pregnancy-related hypertension were randomized to treatment with 200 mg oral labetalol or 10 mg intramuscular hydralazine." | 5.05 | Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. ( Calder, AA; Greer, I; Walker, JJ, 1983) |
| "In an open, controlled trial, treatment with a combination of metoprolol and hydralazine was compared with non-pharmacological management of mild and moderate hypertension in pregnancy." | 5.05 | A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy. ( Axelsson, O; Högstedt, S; Lindberg, BS; Lindeberg, S; Lindmark, G; Rane, A; Sandström, B, 1985) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 5.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| "Twentysix women with pregnancy-induced hypertension have been randomly treated with either labetalol or Aldomet." | 5.05 | Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. ( Broughton Pipkin, F; Lamming, GD; Symonds, EM, 1980) |
| " Plasma renin activity (PRA), the daily urinary excretion of aldosterone (dU-Aldo) and electrolytes were studied before and during dihydralazine therapy (25 mg 3 times daily)." | 5.04 | The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy. ( Lammintausta, R, 1978) |
| " Glyceryl trinitrate and labetalol were associated with fewer incidences of tachycardia and palpitation respectively than hydralazine." | 4.98 | Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. ( Sequeira, RP; Sridharan, K, 2018) |
| "Oral nifedipine, and possibly labetalol and methyldopa, are suitable options for treatment of severe hypertension in pregnancy/postpartum." | 4.90 | Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. ( Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P, 2014) |
| "To review outcomes in randomised controlled trials comparing hydralazine against other antihypertensives for severe hypertension in pregnancy." | 4.82 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. ( Cham, C; Magee, LA; Ohlsson, A; von Dadelszen, P; Waterman, EJ, 2003) |
| "Tradiational drug therapy choices for hypertension in pregnancy continue to be hydralazine for acute reduction of blood pressure and methyldopa for the management of chronic hypertension." | 4.79 | Use of nifedipine in the hypertensive diseases of pregnancy. ( Doering, PL; Hatton, RC; Levin, AC, 1994) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| " The American College of Obstetricians and Gynecologists recommends that acute-onset, severe hypertension be treated with first line-therapy (intravenous labetalol, intravenous hydralazine or oral nifedipine) within 60 minutes to reduce risk of maternal morbidity and death." | 3.96 | Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. ( Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM, 2020) |
| "Acute cocaine intoxication has been associated with elevated blood pressure and placental abruption." | 3.68 | Cocaine intoxication associated with abruptio placentae. ( Clark, JF; Flowers, D; Westney, LS, 1991) |
| "Echocardiography documented fetal premature atrial contractions after maternal hydralazine treatment for hypertension." | 3.67 | Fetal premature atrial contractions associated with hydralazine. ( Feinstein, SJ; Lodeiro, JG; Lodeiro, SB, 1989) |
| " The mother suffered from lupus-like syndrome consequent to hydralazine treatment for pregnancy-induced hypertension." | 3.67 | Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report. ( Bar-Khayim, Y; Dgani, R; Lancet, M; Mogilner, BM; Nissim, F; Shoham, Z; Yemini, M, 1989) |
| "The hemodynamic changes after intravenous administration of hydralazine were assessed using M-mode echocardiography in 13 pregnant patients with severe hypertension." | 3.67 | Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension. ( Kuzniar, J; Piela, A; Skret, A; Szmigiel, Z; Zaczek, T, 1985) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 3.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| "The concentration of "real" and "apparent" (= "real" hydralazine + acid-labile hydrazones) hydralazine in maternal and umbilical plasma obtained at delivery of 6 women treated with hydralazine and atenolol for pregnancy hypertension were measured by gas chromatography." | 3.66 | Transplacental passage and breast milk concentrations of hydralazine. ( Hanson, A; Ingemarsson, I; Liedholm, H; Melander, A; Wåhlin-Boll, E, 1982) |
| "The effects on the fetus of the acute lowering of blood pressure in maternal hypertension with dihydralazine 6." | 3.66 | The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy. ( Moodley, J; Vink, GJ, 1982) |
| "The uteroplacental blood flow was measured in 12 women with hypertension during pregnancy before and after intravenous injection of dihydralazine." | 3.66 | Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. ( Lewander, R; Lunell, NO; Nylund, L; Sarby, B; Thornström, S, 1983) |
| "During phenylephrine-induced hypertension in 6 near-term pregnant ewes, nitroprusside rapidly lowered the blood pressure to control values with no accompanying change in uterine blood flow." | 3.65 | Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes. ( Krames, E; Levinson, G; Ring, G; Shnider, SM; Wallis, KL, 1977) |
| "Hydralazine was found to be superior in its ability to effect more rapidly a lower mean arterial blood pressure." | 2.66 | Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. ( Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM, 1989) |
| " The duration of action also varied in the labetalol group, with the shortest duration occurring in those patients who required the highest dosage for BP control." | 2.66 | A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. ( Amon, E; Gonzalez, AR; Mabie, WC; Sibai, BM, 1987) |
| "The incidence of preeclampsia in the randomized prophylactic antihypertensive group was statistically lower than that in the nonrandomized group (8." | 2.65 | The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies. ( Crenshaw, MC; Dorminy, JH; Gall, SA; Jelovsek, FR; Welt, SI, 1981) |
| "Although acute aortic dissection is a rare complication, an association between pregnancy and aortic dissection has been reported even in the absence of preconception aortic root dilatation." | 2.43 | Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature. ( Elami, A; Ezra, Y; Gilon, D; Ginosar, Y; Pollak, A; Volach, V, 2006) |
| "Preeclampsia is characterized by the triad of hypertension, proteinuria, and edema but these findings are not specific." | 2.40 | [Pregnancy induced hypertension]. ( Suzuki, H, 1997) |
| "Although hypertension is the most common and significant risk factor in pregnancy, the risks can be minimized with careful supervision and therapy." | 2.37 | Hypertension in pregnant women. ( Gallery, ED, 1985) |
| "Hypertension in pregnancy has implications for both maternal and fetal welfare." | 2.37 | Hypertension in pregnancy. Pathophysiology and management. ( Lubbe, WF, 1984) |
| "A 31-year-old woman with dilated cardiomyopathy was not treated with hydralazine during pregnancy and developed worsening heart failure." | 1.40 | Treatment of pre-existing cardiomyopathy during pregnancy. ( Ascoop, AK; De Backer, J; De Pauw, M; Gevaert, S; Roelens, K; Tromp, F, 2014) |
| "Pregnancy-related hypertension is not thought to be an absolute contraindication to glucocorticoid therapy for the induction of pulmonary maturity." | 1.26 | Glucocorticoid therapy for the induction of pulmonary maturity in severely hypertensive gravid women. ( Nochimson, DJ; Petrie, RH, 1979) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 1.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (74.26) | 18.7374 |
| 1990's | 13 (12.87) | 18.2507 |
| 2000's | 4 (3.96) | 29.6817 |
| 2010's | 7 (6.93) | 24.3611 |
| 2020's | 2 (1.98) | 2.80 |
| Authors | Studies |
|---|---|
| Antza, C | 1 |
| Dimou, C | 1 |
| Doundoulakis, I | 1 |
| Akrivos, E | 1 |
| Stabouli, S | 1 |
| Haidich, AB | 1 |
| Goulis, DG | 1 |
| Kotsis, V | 1 |
| Kantorowska, A | 1 |
| Heiselman, CJ | 1 |
| Halpern, TA | 1 |
| Akerman, MB | 1 |
| Elsayad, A | 1 |
| Muscat, JC | 1 |
| Sicuranza, GB | 1 |
| Vintzileos, AM | 1 |
| Heo, HJ | 1 |
| Sridharan, K | 1 |
| Sequeira, RP | 1 |
| Habashi, JP | 1 |
| MacFarlane, EG | 1 |
| Bagirzadeh, R | 1 |
| Bowen, C | 1 |
| Huso, N | 1 |
| Chen, Y | 1 |
| Bedja, D | 1 |
| Creamer, TJ | 1 |
| Rykiel, G | 1 |
| Manning, M | 1 |
| Huso, D | 1 |
| Dietz, HC | 1 |
| Alexander, JM | 1 |
| Wilson, KL | 1 |
| Gevaert, S | 1 |
| De Pauw, M | 1 |
| Tromp, F | 1 |
| Ascoop, AK | 1 |
| Roelens, K | 1 |
| De Backer, J | 1 |
| Firoz, T | 1 |
| Magee, LA | 3 |
| MacDonell, K | 1 |
| Payne, BA | 1 |
| Gordon, R | 1 |
| Vidler, M | 1 |
| von Dadelszen, P | 2 |
| Vadhera, RB | 1 |
| Simon, M | 1 |
| Baggio, MR | 1 |
| Martins, WP | 1 |
| Calderon, AC | 1 |
| Berezowski, AT | 1 |
| Marcolin, AC | 1 |
| Duarte, G | 1 |
| Cavalli, RC | 1 |
| URANGAIMAZ, FA | 2 |
| TONNELIER, E | 1 |
| KLAUER, D | 1 |
| CHEKERDEMIAN, M | 1 |
| Cham, C | 1 |
| Waterman, EJ | 1 |
| Ohlsson, A | 1 |
| Volach, V | 1 |
| Elami, A | 1 |
| Gilon, D | 1 |
| Pollak, A | 1 |
| Ginosar, Y | 1 |
| Ezra, Y | 1 |
| Chesley, LC | 1 |
| Richter, R | 1 |
| Sandström, B | 6 |
| Hayashi, RH | 1 |
| Liedholm, H | 2 |
| Melander, A | 2 |
| Lubbe, WF | 1 |
| Prichard, BN | 1 |
| Liu, TL | 1 |
| Holzgreve, H | 1 |
| Tullio, D | 1 |
| Redman, CW | 4 |
| Skret, A | 2 |
| Kuźniar, J | 2 |
| Piela, A | 2 |
| Zaczek, T | 2 |
| Szmigiel, Z | 2 |
| Lindeberg, S | 3 |
| Lundborg, P | 2 |
| Regårdh, CG | 2 |
| Lunell, NO | 2 |
| Lewander, R | 1 |
| Nylund, L | 2 |
| Sarby, B | 1 |
| Thornström, S | 1 |
| Walker, JJ | 2 |
| Greer, I | 1 |
| Calder, AA | 1 |
| Drayer, JI | 1 |
| Weber, MA | 1 |
| Ovadia, J | 2 |
| Hod, M | 1 |
| Friedman, S | 2 |
| Berkowitz, RL | 2 |
| Vink, GJ | 2 |
| Moodley, J | 4 |
| Wåhlin-Boll, E | 1 |
| Hanson, A | 1 |
| Ingemarsson, I | 1 |
| Welt, SI | 1 |
| Dorminy, JH | 1 |
| Jelovsek, FR | 1 |
| Crenshaw, MC | 1 |
| Gall, SA | 1 |
| Bott-Kanner, G | 3 |
| Schweitzer, A | 2 |
| Reisner, SH | 1 |
| Joel-Cohen, SJ | 1 |
| Rosenfeld, JB | 2 |
| Philpott, RH | 2 |
| Widerlöv, E | 1 |
| Karlman, I | 1 |
| Storsäter, J | 1 |
| Lamming, GD | 1 |
| Broughton Pipkin, F | 1 |
| Symonds, EM | 1 |
| Iams, JD | 1 |
| Semchyshyn, S | 1 |
| O'Shaughnessy, R | 1 |
| Moynihan, V | 1 |
| Zuspan, FP | 1 |
| Gudmundsson, S | 1 |
| Gennser, G | 1 |
| Marsal, K | 1 |
| Levin, AC | 1 |
| Doering, PL | 1 |
| Hatton, RC | 1 |
| Hsueh, WA | 1 |
| Paran, E | 2 |
| Holzberg, G | 1 |
| Mazor, M | 1 |
| Zmora, E | 2 |
| Insler, V | 1 |
| Jegasothy, R | 1 |
| Paranthaman, S | 1 |
| Suzuki, H | 1 |
| Curtis, KS | 1 |
| Cunningham, JT | 1 |
| Heesch, CM | 1 |
| Bull, SB | 1 |
| Koren, G | 1 |
| Logan, A | 1 |
| Hussein, M | 1 |
| Mooij, JM | 1 |
| Roujouleh, H | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Walters, WA | 1 |
| Gant, NF | 2 |
| Madden, JD | 1 |
| Siiteri, PK | 1 |
| MacDonald, PC | 1 |
| Lammintausta, R | 1 |
| Curet, LB | 1 |
| Olson, RW | 1 |
| Arias, F | 1 |
| Zamora, J | 1 |
| Nochimson, DJ | 1 |
| Petrie, RH | 1 |
| Worley, RJ | 1 |
| Cunningham, FG | 1 |
| Whalley, PJ | 1 |
| Schoenfeld, A | 1 |
| Joel-Cohen, J | 1 |
| Ring, G | 1 |
| Krames, E | 1 |
| Shnider, SM | 1 |
| Wallis, KL | 1 |
| Levinson, G | 1 |
| Woods, JR | 1 |
| Brinkman, CR | 1 |
| Duggan, PM | 1 |
| McCowan, LM | 1 |
| Stewart, AW | 1 |
| Fairlie, FM | 1 |
| Phippard, AF | 1 |
| Fischer, WE | 1 |
| Horvath, JS | 2 |
| Child, AG | 1 |
| Korda, AR | 1 |
| Henderson-Smart, D | 2 |
| Duggin, GG | 2 |
| Tiller, DJ | 2 |
| Flowers, D | 1 |
| Clark, JF | 1 |
| Westney, LS | 1 |
| Harper, A | 1 |
| Murnaghan, GA | 1 |
| Plouin, PF | 1 |
| Breart, G | 1 |
| Llado, J | 1 |
| Dalle, M | 1 |
| Keller, ME | 1 |
| Goujon, H | 1 |
| Berchel, C | 1 |
| Derham, RJ | 1 |
| Hawkins, DF | 1 |
| De Vries, LS | 1 |
| Aber, VR | 1 |
| Elder, MG | 1 |
| Yemini, M | 1 |
| Shoham, Z | 1 |
| Dgani, R | 1 |
| Lancet, M | 1 |
| Mogilner, BM | 1 |
| Nissim, F | 1 |
| Bar-Khayim, Y | 1 |
| Griffis, KR | 1 |
| Martin, JN | 1 |
| Palmer, SM | 1 |
| Martin, RW | 1 |
| Morrison, JC | 2 |
| Chervenak, FA | 1 |
| Gallery, ED | 2 |
| Naden, RP | 1 |
| Durando, C | 1 |
| Leidi, L | 1 |
| Margaria, E | 1 |
| Medaglia, M | 1 |
| Gessa, M | 1 |
| Maina, G | 1 |
| Rubin, PC | 1 |
| Widerhorn, J | 1 |
| Rubin, JN | 1 |
| Frishman, WH | 1 |
| Elkayam, U | 1 |
| Easterling, TR | 1 |
| Benedetti, TJ | 1 |
| Schmucker, BC | 1 |
| Carlson, KL | 1 |
| Lodeiro, JG | 1 |
| Feinstein, SJ | 1 |
| Lodeiro, SB | 1 |
| Sullivan, JM | 1 |
| Holm, B | 1 |
| Mabie, WC | 1 |
| Gonzalez, AR | 1 |
| Sibai, BM | 2 |
| Amon, E | 1 |
| Brengman, SL | 1 |
| Burns, MK | 1 |
| Ashe, RG | 1 |
| Richards, AM | 1 |
| Vasant, RV | 1 |
| Spinnato, JA | 1 |
| Anderson, GD | 1 |
| Suonio, S | 1 |
| Saarikoski, S | 1 |
| Tahvanainen, K | 1 |
| Pääkkönen, A | 1 |
| Olkkonen, H | 1 |
| Rosenfeld, J | 1 |
| Boner, G | 1 |
| Nissenkorn, A | 1 |
| Merlob, P | 1 |
| Reisner, S | 1 |
| Lipshitz, J | 1 |
| Ahokas, RA | 1 |
| Reynolds, SL | 1 |
| Högstedt, S | 1 |
| Axelsson, O | 1 |
| Lindmark, G | 1 |
| Rane, A | 1 |
| Lindberg, BS | 1 |
| Ross, MR | 1 |
| Gyory, AZ | 1 |
| Redgrave, JE | 1 |
| Swartz, SL | 1 |
| Whitworth, NS | 1 |
| Bates, GW | 1 |
| McKay, ML | 1 |
| Gookin, KS | 1 |
| Wiser, WL | 1 |
| Friesen, HG | 1 |
| Korda, A | 1 |
| Child, A | 1 |
| Phippard, A | 1 |
| Hall, BM | 1 |
| Cotton, DB | 1 |
| Gonik, B | 1 |
| Dorman, KF | 1 |
| Fernandes, M | 1 |
| Kim, KE | 1 |
| Moyer, JH | 1 |
| Wilber, JA | 1 |
| Ragni, N | 1 |
| Cadenelli, GP | 1 |
| Harley, JM | 1 |
25 reviews available for hydralazine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
The flipside of hydralazine in pregnancy: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Birth Weight; Female; Heart Rate; Humans; Hydralazine; Hypertension; Hypert | 2020 |
Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Hydralazine; Hy | 2018 |
Hypertensive emergencies of pregnancy.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; | 2013 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy- | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hyperten | 2014 |
Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
Topics: Antihypertensive Agents; Blood Pressure; Bradycardia; Female; Heart Rate, Fetal; Humans; Hydralazine | 2003 |
Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Aortic Diseases; Aortic Dissection; Blo | 2006 |
The control of hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Antihypertensive Agents; Diazoxide; Diuretics; Eclampsi | 1981 |
Management of the pregnant patient with chronic hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Humans; Hydralaz | 1983 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clon | 1984 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
[Arterial hypertension in pregnancy. Concise review].
Topics: Cesarean Section; Diet, Sodium-Restricted; Female; Humans; Hydralazine; Hypertension; Labor, Induced | 1983 |
The management of hypertension in pregnancy.
Topics: Cerebrovascular Circulation; Clinical Trials as Topic; Diazoxide; Diuretics; Female; Humans; Hydrala | 1984 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide | 1980 |
Treatment of hypertension in pregnancy.
Topics: Diazoxide; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyldopa; Placenta; Pre-Eclampsia | 1980 |
Use of nifedipine in the hypertensive diseases of pregnancy.
Topics: Female; Humans; Hydralazine; Hypertension; Nifedipine; Pre-Eclampsia; Pregnancy; Pregnancy Complicat | 1994 |
[Pregnancy induced hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bed Rest; Contraindications; Fema | 1997 |
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Cohort Studies; Databases as Topic; Diabetes, Gestational; Femal | 2001 |
The use of antihypertensive drugs in hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Diuretic | 1977 |
Hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Animals; Chronic Disease; Clonidine; Diuretics; Female; Humans; Hydrala | 1985 |
Hypertension in pregnant women.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Delivery, Obstetric; Diazoxide; Emergencies; F | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; H | 1985 |
Treatment of hypertension in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Eclampsia; Female; Human | 1986 |
Cardiovascular drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digoxin; Female; Humans; | 1987 |
Hypertensive emergencies.
Topics: Acute Kidney Injury; Adrenal Gland Neoplasms; Antihypertensive Agents; Aortic Aneurysm; Blood Volume | 1974 |
19 trials available for hydralazine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
Topics: Acute Disease; Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Labetalol; | 2011 |
The management of hypertension in pregnancy.
Topics: Cerebrovascular Circulation; Clinical Trials as Topic; Diazoxide; Diuretics; Female; Humans; Hydrala | 1984 |
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
Topics: Ethanolamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pregnanc | 1983 |
The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies.
Topics: Adult; Antihypertensive Agents; Birth Weight; Blood Pressure; Body Weight; Female; Humans; Hydralazi | 1981 |
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; | 1980 |
Effects of hydralazine on placental and renal circulation in pre-eclampsia.
Topics: Adult; Birth Weight; Blood Circulation; Blood Flow Velocity; Blood Pressure; Drug Evaluation; Female | 1995 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female | 1995 |
Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice.
Topics: Administration, Sublingual; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hydra | 1996 |
The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
Topics: Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Dihydralazine; Electrolytes; Female; H | 1978 |
Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.
Topics: Arteries; Blood Flow Velocity; Double-Blind Method; Female; Humans; Hydralazine; Hypertension; Nifed | 1992 |
Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension.
Topics: Adult; Birth Weight; Blood Pressure; Clonidine; Double-Blind Method; Drug Administration Schedule; D | 1991 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Heart Rate, Fetal; Hemodynamics; Hum | 1991 |
A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension.
Topics: Adult; Birth Weight; Cesarean Section; Dihydralazine; Double-Blind Method; Drug Therapy, Combination | 1990 |
Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
Topics: Blood Pressure; Fees, Pharmaceutical; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; | 1989 |
A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; H | 1987 |
Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.
Topics: Blood Pressure; Clinical Trials as Topic; Dihydralazine; Female; Heart Rate; Heart Rate, Fetal; Huma | 1987 |
Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pindolo | 1986 |
A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fetus; Gestational Age; Humans; | 1985 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Ne | 1985 |
58 other studies available for hydralazine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; | 2020 |
Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Aortic Dissection; Disease Models, Animal; Female; Hydr | 2019 |
Treatment of pre-existing cardiomyopathy during pregnancy.
Topics: Adult; Antihypertensive Agents; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Heart Failure; H | 2014 |
[THERAPEUTICS OF ARTERIAL HYPERTENSION IN PREGNANCY].
Topics: Female; Guanethidine; Hibernation; Humans; Hydralazine; Hypertension; Hypothermia, Induced; Maternal | 1964 |
[Antihypertensive therapy in pregnancy].
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Clonidine; Female; Humans; Hydralazine; Hydro | 1982 |
Adrenergic beta-receptor blockers in hypertension of pregnancy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Birth Weight; Blood Pressure; Delivery, Obstetric; F | 1982 |
Drug selection in the treatment of pregnancy hypertension. A survey.
Topics: Adrenal Glands; Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Card | 1984 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt | 1984 |
Therapeutic regime on pregnancy induced hypertension.
Topics: Dextrans; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; I | 1982 |
[Forum on hypertension. Part 8. Hypertension management in pregnancy].
Topics: Antihypertensive Agents; Dihydralazine; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyl | 1981 |
[Hemodynamic response to hydralazine in pregnant women with hypertension].
Topics: Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complic | 1984 |
Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate.
Topics: Amniotic Fluid; Drug Therapy, Combination; Female; Fetal Blood; Humans; Hydralazine; Hypertension; I | 1984 |
Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy.
Topics: Blood Pressure; Dihydralazine; Female; Heart Rate; Humans; Hydralazine; Hypertension; Placenta; Pre- | 1983 |
Antihypertensive therapy during pregnancy.
Topics: Antihypertensive Agents; Diuretics; Female; Humans; Hydralazine; Hypertension; Methyldopa; Pregnancy | 1983 |
Severe consequence of hypertension in pregnancy.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hydralazine; Hypertension; Pre-Eclampsia; Pr | 1983 |
The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy.
Topics: Blood Pressure; Depression, Chemical; Dihydralazine; Female; Fetal Growth Retardation; Fetal Heart; | 1982 |
Transplacental passage and breast milk concentrations of hydralazine.
Topics: Adult; Breast Feeding; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Maternal-Fetal Ex | 1982 |
Propranolol and hydrallazine in the management of essential hypertension in pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypoglycemia; Infant, N | 1980 |
Effect of dihydralazine on the fetus in the treatment of maternal hypertension.
Topics: Birth Weight; Dihydralazine; Female; Fetal Death; Fetal Growth Retardation; Fetal Heart; Fetal Monit | 1980 |
Hydralazine-induced neonatal thrombocytopenia.
Topics: Adult; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Pre-Ec | 1980 |
Blood pressure response in hypertensive pregnancies treated with cortisol.
Topics: Adolescent; Adult; Blood Pressure; Drug Therapy, Combination; Ethanol; Female; Humans; Hydralazine; | 1980 |
Pre-eclampsia and hypertension in pregnancy.
Topics: Antihypertensive Agents; Contraindications; Female; Guidelines as Topic; Hospitalization; Humans; Hy | 1994 |
Fos expression in brain stem nuclei of pregnant rats after hydralazine-induced hypotension.
Topics: Animals; Antihypertensive Agents; Brain Stem; Cerebral Ventricles; Female; Hydralazine; Hypotension; | 1999 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; | 2001 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Review: the significance and management of raised blood pressure in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Chlormethiazole; Clonidine; Diazepam; D | 1979 |
The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension, and naturesis in normal and hypertensive pregnancies.
Topics: Adult; Angiotensin II; Blood Pressure; Dehydroepiandrosterone; Female; Furosemide; Humans; Hydralazi | 1976 |
Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy.
Topics: Bed Rest; Birth Weight; Chronic Disease; Female; Fetal Death; Humans; Hydralazine; Hypertension; Inf | 1979 |
Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension.
Topics: Adult; Antihypertensive Agents; Chronic Disease; Female; Fetal Growth Retardation; Fetus; Growth; Hu | 1979 |
Glucocorticoid therapy for the induction of pulmonary maturity in severely hypertensive gravid women.
Topics: Betamethasone; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Labor, Induced; Pre-Eclam | 1979 |
Clinical management of pregnancy-induced hypertension.
Topics: Age Factors; Ambulatory Care; Delivery, Obstetric; Female; Gestational Age; Hospitalization; Humans; | 1978 |
Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pregnancy; Pregnancy Co | 1978 |
Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy.
Topics: Apgar Score; Drug Evaluation; Drug Therapy, Combination; Female; Fetal Growth Retardation; Fetus; Hu | 1978 |
Comparison of nitroprusside and hydralazine in hypertensive pregnant ewes.
Topics: Animals; Cardiac Output; Female; Ferricyanides; Heart Rate; Hydralazine; Hypertension; Nitroprusside | 1977 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
Topics: Female; Heart Rate, Fetal; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Pregnancy; Pr | 1991 |
Cocaine intoxication associated with abruptio placentae.
Topics: Abruptio Placentae; Adult; Cocaine; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Pr | 1991 |
Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors.
Topics: Adult; Birth Weight; Cerebral Hemorrhage; Cesarean Section; Female; Fetal Growth Retardation; Gestat | 1989 |
Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report.
Topics: Adult; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Lupus Vulgaris; Pregnancy; Pregna | 1989 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; H | 1985 |
Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring.
Topics: Atenolol; Cardiac Output; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Pregnancy; Pregna | 1989 |
Fetal premature atrial contractions associated with hydralazine.
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Echocardiography; Female; Fetal Diseases; Heart Rate; H | 1989 |
Elevated blood pressure during pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Me | 1986 |
The effect of hydralazine on steady-state plasma concentrations of metoprolol in pregnant hypertensive women.
Topics: Adult; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Meto | 1988 |
Dihydralazine and the uteroplacental blood flow.
Topics: Dihydralazine; Female; Humans; Hydralazine; Hypertension; Placenta; Pregnancy; Pregnancy Complicatio | 1988 |
Hypertensive crisis in L & D.
Topics: Adult; Critical Care; Diazoxide; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Nitro | 1988 |
The use of dihydralazine infusion in the management of severe hypertension in pregnancy.
Topics: Adult; Dihydralazine; Female; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Pregnancy; | 1986 |
Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension.
Topics: Acute Disease; Cesarean Section; Eclampsia; Female; Fetal Distress; Gestational Age; Humans; Hydrala | 1986 |
Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
Topics: Adult; Blood Pressure; Blood Volume; Cardiac Output; Chorionic Villi; Dihydralazine; Female; Furosem | 1986 |
The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Female; Hydralazine; Hypertension; Perfusion; Placenta; Pregnancy; | 1987 |
Diagnosis and management of malignant hypertension.
Topics: Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Malignant; Kidney Function Tests | 1985 |
Plasma prolactin concentrations and pregnancy-induced hypertension.
Topics: Adult; Apgar Score; Birth Weight; Circadian Rhythm; Female; Gestational Age; Humans; Hydralazine; Hy | 1985 |
Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation.
Topics: Antihypertensive Agents; Clonidine; Diazoxide; Female; Humans; Hydralazine; Hypertension; Infant Mor | 1985 |
Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hydralazine; Hypertension; Pregna | 1985 |
Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
Topics: Blood Pressure; Body Surface Area; Cardiac Output; Echocardiography; Female; Hemodynamics; Humans; H | 1985 |
The management of hypertension during pregnancy.
Topics: Adolescent; Adult; Blood Pressure; Clinical Laboratory Techniques; Diagnosis, Differential; Dihydrox | 1972 |
[On a new hypotensive pharmacological association in pregnancy with hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbamates; Creatinine; Electrolytes; Female; Humans | 1971 |
Essential hypertension complicating pregnancy: Factors affecting the fetal mortality.
Topics: Adult; Female; Fetal Death; Humans; Hydralazine; Hypertension; Middle Aged; Pregnancy; Pregnancy Com | 1966 |